This abnormality in insulin secretion is initially manifested as increased/exaggerated secretion as a compensatory response to insulin resistance (stages of IGT and pre-IGT), but which subsequently manifests a progressive decline in insulin secretion as beta-cell failure emerges and hyperglycaemia supervenes (DM). Here, INS is linked to Insulin resistance.